Prevalence and characterization of post-acute sequelae of SARS-CoV-2 infection (PASC) in Rwanda
Approximately one-third of adult Rwandan COVID-19 survivors continue to experience persistent symptoms. This burden signals that post-COVID care must become an integral part of routine health services, especially as new variants periodically drive fresh waves of infection. Preventing repeat infections and integrating mental health support emerge as actionable priorities. Harmonized longitudinal studies are needed to clarify PASC causality.
Authors
- Eric Remera (ORCID: https://orcid.org/0000-0002-6084-8877)
- Edson Rwagasore (ORCID: https://orcid.org/0009-0006-5002-0829)
- Vivianne Umuhire Niyonkuru
- Gilbert Rukundo (ORCID: https://orcid.org/0000-0003-1054-4039)
- Charles Ruranga (ORCID: https://orcid.org/0000-0002-5456-7454)
- Fernand Rwamwejo (ORCID: https://orcid.org/0000-0002-0814-723X)
- Elizabeth Krebs (ORCID: https://orcid.org/0000-0003-4905-9700)
- Les Sztandera
Institutions
- Thomas Jefferson University (US)
- University of Rwanda (RW)
- Rwanda Biomedical Center (RW)
- Ministry of Health (RW)
Publication Details
- Journal
- IJID Regions
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1016/j.ijregi.2025.100738
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer